VivoSeq
Other

Local

0

Pipeline Programs↗

1

Active Trials↗

12

Companies Involved↗

Local is an early-stage landscape with 0 programs across 12 companies. The most active players are Pfizer, AstraZeneca, GSK.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

89/100

Attrition Rate

9/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Pfizer logo

Pfizer

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

PreclinicalGSK logo

GSK

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

PreclinicalTeva logo

Teva

0 programs

PreclinicalM

Merz Pharmaceuticals GmbH

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

44

clinical trials

Completed32 · 73%
Unknown status5 · 11%
Terminated2 · 5%
Withdrawn2 · 5%
No longer available1 · 2%
Available1 · 2%
Other1 · 2%

Clinical Trials

Trial Activity

44 trials

Mixed Local for Sciatic Block
Not yet recruiting·LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·N/A·NCT06671028·110 enrolled
Application of Transversus Abdominus Plain Block, Local Subcutaneous Injection and IV Nalbuphine
Completed·EEgymedicalpedia·Phase 1·NCT05276206·400 enrolled
ATOM_local Ablative Therapy
Completed·—·Phase 2·NCT01941654·18 enrolled
Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT01592214·48 enrolled
Transcricoid Injection vs. Spray as You go Method for Local Anaesthesia During EBUS-TBNA
Completed·—·N/A·NCT02981264·365 enrolled
Study To Assess Local Tolerability of Crisaborole 2% Ointment and Vehicle Ointment In Healthy Participants Using Subject-reported Assessments and Objective Measurements
Completed·Pfizer logoPfizer·Phase 1·NCT03760042·32 enrolled
Comparison Between Microneedling Daycare Procedure and Tazarotene 0.1% Gel Local Application in Acne Scarring
Completed·PPost Graduate Institute of Medical Education and Research, Chandigarh·N/A·NCT03170596·36 enrolled
The Effect of Antioxidants on Skin Blood Flow During Local Heating
Completed·TThe University of Texas at Arlington·Phase 1·NCT03680638·44 enrolled
Local Phase 4 Pan-European SMART Study
Completed·AstraZeneca logoAstraZeneca·Phase 4·NCT00463866·8,424 enrolled
Painless Local Anaesthesia With Bicarbonate Admixture
Completed·UUniversity of Zurich·Phase 2·NCT03238625·48 enrolled
ZOSTAVAX(R) Local Registration Trial (V211-019)
Completed·Merck & Co. logoMerck & Co.·Phase 3·NCT00444860·150 enrolled
A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046
Completed·Teva logoTeva·Phase 1·NCT03700658·27 enrolled
Safety Study Investigating Local Tolerability and Pharmacokinetics of PXL01 in Healthy Volunteers
Completed·PPharmaSurgics AB·Phase 1·NCT00860080·15 enrolled
Local Study of Akatinol Memantine in VaD in Russia
Completed·MMerz Pharmaceuticals GmbH·Phase 3·NCT03986424·130 enrolled
Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers
Completed·Novartis logoNovartis·Phase 4·NCT00135824·30 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)